Technology News and Research

RSS

Betalin launches new EMP technology that could transform diabetes treatment

Betalin Therapeutics, a biotech company specializing in tissue engineering for curing diabetes, introduces the Engineered Micro Pancreas (EMP), a novel technology that provides significant levels of glucose-regulated insulin secretion over extended periods of time.

11 Nov 2015

Research opens door for developing biomarker tests to detect cancers early

Biomarkers, which allow diseases to be diagnosed and staged based on relatively non-invasive blood tests, have been identified for several types of cancers, but for most cancers remain elusive. Now, research conducted at the RIKEN Center for Life Science Technologies in Japan and the Harry Perkins Institute of Medical Research in Australia has identified a large number of genes that are upregulated in many different types of cancer, opening the door for developing biomarker tests that could be used to detect cancers early, allowing for prompt treatment.

10 Nov 2015

Purple Button mobile app helps HMC achieve overall goal of improving patient safety, quality

CRG Medical officially announced today the implementation of the ONC for IT award winning Purple Button mobile patient safety application at HMC. The Purple Button, powered by CRG Medical, supports the KB Core High Reliability Patient Safety Evaluation System and has been instrumental in assisting HMC toward their overall goal of improving patient safety, quality and satisfaction.

10 Nov 2015

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

New Haven Pharmaceuticals, Inc. today announced new study data that shows the company's FDA-approved drug DURLAZA delivers sustained antiplatelet control for a full 24-hour period in high-risk patients.

10 Nov 2015

SKYGEN USA announces launch of Hylis Pharmacy Solutions

Citing a need to bring skyrocketing pharmacy costs under control, SKYGEN USA, the umbrella brand for a distinguished family of benefit management companies and technology solutions for health payers and healthcare organizations, today announced the launch of Hylis Pharmacy Solutions.

10 Nov 2015

Deep, uniform exome coverage in one day

Integrated DNA Technologies (IDT), introduces its new xGen® Exome Research Panel v1.0 for insightful analysis of the human exome via next generation sequencing.

From Integrated DNA Technologies 10 Nov 2015

VISERA 4K UHD endoscopy system gives surgeons 4x resolution

Olympus launches the VISERA 4K UHD system across the UK. Surgeons will benefit from particularly sharp images thanks to integration of 4K Ultra HD technology.

From Evident - Medical and Surgical 10 Nov 2015

New vaccine appears to be more effective in reducing 'bad' LDL cholesterol

A new cholesterol-lowering vaccine leads to reductions in 'bad' LDL cholesterol in mice and macaques, according to research published in Vaccine. The authors of the study, from the University of New Mexico and the National Institutes of health in the United States, say the vaccine has the potential to be a more powerful treatment than statins alone.

10 Nov 2015

Ambulances deployed at temporary locations can reduce response time, save lives

Ambulances deployed at temporary locations that can be changed depending on the time of day and accident statistics can reduce response time and may save lives on the way to the hospital. Researchers at Sahlgrenska University studied fluid deployment of ambulances in Shiraz, Iran.

10 Nov 2015

Public policy needed to reduce stem cell tourism, say experts

The continued marketing and use of experimental stem cell-based interventions inside and outside the United States is problematic and unsustainable, according to a new paper by science policy and bioethics experts at Rice University's Baker Institute for Public Policy and Wake Forest University.

10 Nov 2015

PAREXEL expands market access and clinical evidence services

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced expanded evidence-based services for biopharmaceutical products.

10 Nov 2015

St. Jude and Scripps Research Institute scientists help launch Human Dark Proteome Initiative

Scientists at St. Jude Children’s Research Hospital, The Scripps Research Institute (TSRI) and other institutions today announced the launch of the Human Dark Proteome Initiative (HDPI). The initiative aims to accelerate research into biology’s “invisible mass” to provide novel insights into cell function and a new frontier in drug discovery.

9 Nov 2015

Glan Clwyd Hospital N Wales invest in Esaote's G-Scan MRI unit for weight-bearing scanning

Glan Clwyd Hospital in North Wales has become the first publicly-funded hospital in the UK to invest in Esaote’s G-scan Brio, an open, weight-bearing MRI unit for musculoskeletal scanning. In an innovative move, the hospital can now scan patients in any position, from standing vertically to the traditional supine postition laying flat.

9 Nov 2015

Oasmia Pharmaceutical’s Paclical is bioequivalent of Celgene’s Abraxane in treatment of women with metastatic breast cancer

Oasmia Pharmaceutical AB, a developer of a new generation of drugs within human and veterinary oncology, confirmed today the previously published findings from a head-to-head comparison study of its lead human cancer product Paclical and Celgene’s Abraxane, demonstrated superimposable paclitaxel PK profiles. The study was conducted in women with metastatic breast cancer.

9 Nov 2015

Armaron Bio starts Phase 2 trial for novel lead candidate drug for heart failure

Armaron Bio, a Melbourne-based drug development company focused on heart failure and other diseases, is pleased to announce that it has begun its Phase II clinical trial for NP202, its novel lead candidate drug for heart failure.

9 Nov 2015

First comprehensive genomic and biologic study of top skin disease-causing microbes

An international team of scientists, led by researchers from A*STAR's Genome Institute of Singapore (GIS), Institute of Medical Biology (IMB), and Bioinformatics Institute (BII), and P&G, have completed the first comprehensive genomic and biologic study of all species of Malassezia, one of the top skin disease-causing microbes.

9 Nov 2015

HIFU Prostate Services announces groundbreaking partnerships to offer prostate cancer treatments

HIFU Prostate Services, LLC, a leading provider of minimally-invasive prostate cancer treatment using High Intensity Focused Ultrasound ("HIFU"), announces groundbreaking partnerships with Michael J. Lazar, MD in Santa Rosa, Calif. and John H. Jurige, MD in Louisville, Ky., to offer HIFU treatments for prostate cancer.

9 Nov 2015

Nightstar announces $35 million Series B financing round

NightstaRx Ltd, a biopharmaceutical company specialising in developing gene therapies for inherited retinal dystrophies, announces a $35 million Series B financing round. The round was led by New Enterprise Associates, one of the world's leading venture capital firms.

9 Nov 2015

Seven new nCounter PanCancer profiles launched to deeply probe cancer biology

NanoString Technologies, Inc.a provider of life science tools for translational research and molecular diagnostic products, today announced the expansion of its 3D Biology™ portfolio with the commercial launch of the nCounter® PanCancer Profiles, seven new gene expression panels each designed to interrogate a focused area of cancer biology including immuno-oncology.

9 Nov 2015

Dusseldorf will be the meeting point for MEDICA and COMPAMED this week

In the coming week, from 16 to 19 November 2015, Düsseldorf will again become the central meeting point of the international health business. Then, for the first time on the new set of dates from Monday to Thursday (previously: Wednesday to Saturday), the world’s largest medical trade fair, MEDICA, and the international leading supplier specialist trade fair, COMPAMED taking place at the same time, are going to start.

9 Nov 2015

Technology News and Research

Betalin launches new EMP technology that could transform diabetes treatment

Research opens door for developing biomarker tests to detect cancers early

Purple Button mobile app helps HMC achieve overall goal of improving patient safety, quality

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

SKYGEN USA announces launch of Hylis Pharmacy Solutions

Deep, uniform exome coverage in one day

VISERA 4K UHD endoscopy system gives surgeons 4x resolution

New vaccine appears to be more effective in reducing 'bad' LDL cholesterol

Ambulances deployed at temporary locations can reduce response time, save lives

Public policy needed to reduce stem cell tourism, say experts

PAREXEL expands market access and clinical evidence services

St. Jude and Scripps Research Institute scientists help launch Human Dark Proteome Initiative

Glan Clwyd Hospital N Wales invest in Esaote's G-Scan MRI unit for weight-bearing scanning

Oasmia Pharmaceutical’s Paclical is bioequivalent of Celgene’s Abraxane in treatment of women with metastatic breast cancer

Armaron Bio starts Phase 2 trial for novel lead candidate drug for heart failure

First comprehensive genomic and biologic study of top skin disease-causing microbes

HIFU Prostate Services announces groundbreaking partnerships to offer prostate cancer treatments

Nightstar announces $35 million Series B financing round

Seven new nCounter PanCancer profiles launched to deeply probe cancer biology

Dusseldorf will be the meeting point for MEDICA and COMPAMED this week

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News